These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 9136455)
1. FIV infection of the domestic cat: an animal model for AIDS. Willett BJ; Flynn JN; Hosie MJ Immunol Today; 1997 Apr; 18(4):182-9. PubMed ID: 9136455 [No Abstract] [Full Text] [Related]
2. Mechanism(s) of FIV vaccine protection. Pu R; Tellier MC; Yamamoto JK Leukemia; 1997 Apr; 11 Suppl 3():98-101. PubMed ID: 9209311 [TBL] [Abstract][Full Text] [Related]
3. Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine. Yamamoto JK; Pu R; Sato E; Hohdatsu T AIDS; 2007 Mar; 21(5):547-63. PubMed ID: 17314517 [No Abstract] [Full Text] [Related]
6. Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18. Dunham SP; Flynn JN; Rigby MA; Macdonald J; Bruce J; Cannon C; Golder MC; Hanlon L; Harbour DA; Mackay NA; Spibey N; Jarrett O; Neil JC Vaccine; 2002 Feb; 20(11-12):1483-96. PubMed ID: 11858854 [TBL] [Abstract][Full Text] [Related]
7. Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif. Leutenegger CM; Boretti FS; Mislin CN; Flynn JN; Schroff M; Habel A; Junghans C; Koenig-Merediz SA; Sigrist B; Aubert A; Pedersen NC; Wittig B; Lutz H J Virol; 2000 Nov; 74(22):10447-57. PubMed ID: 11044089 [TBL] [Abstract][Full Text] [Related]
8. Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents. Gardner MB Antiviral Res; 1991 May; 15(4):267-86. PubMed ID: 1659310 [TBL] [Abstract][Full Text] [Related]
9. Advances in FIV vaccine technology. Uhl EW; Martin M; Coleman JK; Yamamoto JK Vet Immunol Immunopathol; 2008 May; 123(1-2):65-80. PubMed ID: 18295907 [TBL] [Abstract][Full Text] [Related]
10. The development of a vaccine against feline immunodeficiency virus. Hosie MJ Br Vet J; 1994; 150(1):25-39. PubMed ID: 8025833 [TBL] [Abstract][Full Text] [Related]
11. Feline immunodeficiency virus model for designing HIV/AIDS vaccines. Yamamoto JK; Sanou MP; Abbott JR; Coleman JK Curr HIV Res; 2010 Jan; 8(1):14-25. PubMed ID: 20210778 [TBL] [Abstract][Full Text] [Related]
12. DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus. Cuisinier AM; Mallet V; Meyer A; Caldora C; Aubert A Vaccine; 1997 Jul; 15(10):1085-94. PubMed ID: 9269051 [TBL] [Abstract][Full Text] [Related]
13. Feline immunodeficiency virus as a model for AIDS vaccination. Jarrett O; Yamamoto JK; Neil JC AIDS; 1990; 4 Suppl 1():S163-5. PubMed ID: 1967108 [No Abstract] [Full Text] [Related]
14. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats. Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250 [TBL] [Abstract][Full Text] [Related]
15. FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection. Lutz H; Hofmann-Lehmann R; Bauer-Pham K; Holznagel E; Tozzini F; Bendinelli M; Reubel G; Aubert A; Davis D; Cox D Vet Immunol Immunopathol; 1995 May; 46(1-2):103-13. PubMed ID: 7618250 [TBL] [Abstract][Full Text] [Related]
16. AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts. Giannecchini S; Isola P; Sichi O; Matteucci D; Pistello M; Zaccaro L; Del Mauro D; Bendinelli M J Virol; 2002 Jul; 76(14):6882-92. PubMed ID: 12072489 [TBL] [Abstract][Full Text] [Related]
17. An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection. Aranyos AM; Roff SR; Pu R; Owen JL; Coleman JK; Yamamoto JK Vaccine; 2016 Mar; 34(12):1480-8. PubMed ID: 26802606 [TBL] [Abstract][Full Text] [Related]
18. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine. Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 p24 vaccine protects cats against feline immunodeficiency virus infection. Coleman JK; Pu R; Martin M; Sato E; Yamamoto JK AIDS; 2005 Sep; 19(14):1457-66. PubMed ID: 16135898 [TBL] [Abstract][Full Text] [Related]
20. Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus. Dunham SP; Bruce J; Klein D; Flynn JN; Golder MC; MacDonald S; Jarrett O; Neil JC Vaccine; 2006 Nov; 24(49-50):7095-108. PubMed ID: 17049683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]